NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.
NEW CANAAN, CT— Albert Z. Kapikian, MD, physician, medical pioneer and viral diseases researcher, received the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.
Recent outbreaks of a deadly diarrheal disease in Central America have galvanized national leaders, doctors, nurses and parents, as they battle against the killer disease known as rotavirus. Though it affects rich and poor children alike, the disease causes most of its devastation in developing countries, where rotavirus strikes mainly infants and young children; each year approximately 500,000 children around the world die from the disease.
WASHINGTON, DC, January 26, 2005—Clinical trials to test the safety of a first-of-its-kind human hookworm vaccine will begin in the Washington, DC area in a couple of months after the U.S. Food and Drug Administration conferred investigational new drug status on the vaccine.
Sabin/GW Researchers Receive Word on Investigational New Drug Status for Vaccine
July 7, 2004
NEW CANAAN, CT — Fever, cough, aches and chills mean one thing to most of us as the winter months draw near—influenza, the flu, is circulating again in our community. If we could avoid the misery and potential complications, most of us would choose to do so. Each year, we hope there will be plentiful vaccine, yet once again we have scarce supply.
Flu Vaccine Experts from Sabin Vaccine Institute and CDC, Present Davidoff-Sabin Health Scie